Cryo-Cell Research and Development Expenses 2010-2025 | CCEL
Cryo-Cell research and development expenses from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Cryo-Cell Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $1 |
| 2023 | $1 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Cryo-Cell Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-05-31 | $0 |
| 2025-02-28 | $0 |
| 2024-11-30 | $0 |
| 2024-08-31 | $0 |
| 2024-05-31 | $0 |
| 2024-02-29 | $1 |
| 2023-11-30 | $0 |
| 2023-08-31 | $0 |
| 2023-05-31 | $0 |
| 2023-02-28 | $0 |
| 2022-11-30 | $0 |
| 2022-08-31 | $0 |
| 2022-05-31 | $0 |
| 2022-02-28 | $0 |
| 2021-11-30 | $0 |
| 2021-08-31 | $0 |
| 2021-05-31 | $0 |
| 2021-02-28 | $0 |
| 2020-11-30 | $0 |
| 2020-08-31 | $0 |
| 2020-05-31 | $0 |
| 2020-02-29 | $0 |
| 2019-11-30 | $0 |
| 2019-08-31 | $0 |
| 2019-05-31 | $0 |
| 2019-02-28 | $0 |
| 2018-11-30 | $0 |
| 2018-08-31 | $0 |
| 2018-05-31 | $0 |
| 2018-02-28 | $0 |
| 2017-11-30 | $0 |
| 2017-08-31 | $0 |
| 2017-05-31 | $0 |
| 2017-02-28 | $0 |
| 2016-11-30 | $0 |
| 2016-08-31 | $0 |
| 2016-05-31 | $0 |
| 2016-02-29 | $0 |
| 2015-11-30 | $0 |
| 2015-08-31 | $0 |
| 2015-05-31 | $0 |
| 2015-02-28 | $0 |
| 2014-11-30 | $0 |
| 2014-08-31 | $0 |
| 2014-05-31 | $0 |
| 2014-02-28 | $0 |
| 2013-11-30 | $0 |
| 2013-08-31 | $0 |
| 2013-05-31 | $0 |
| 2013-02-28 | $0 |
| 2012-11-30 | $0 |
| 2012-08-31 | $0 |
| 2012-05-31 | $0 |
| 2012-02-29 | $0 |
| 2011-11-30 | $0 |
| 2011-08-31 | $0 |
| 2011-05-31 | $0 |
| 2011-02-28 | $0 |
| 2010-11-30 | $0 |
| 2010-08-31 | $0 |
| 2010-05-31 | $0 |
| 2010-02-28 | $0 |
| 2009-11-30 | $0 |
| 2009-08-31 | $0 |
| 2009-05-31 | $0 |
| 2009-02-28 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.039B | $0.032B |
| CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.405B | 26.15 |
| CVS Health (CVS) | United States | $80.076B | 9.95 |
| Elevance Health (ELV) | United States | $68.334B | 9.16 |
| Cencora (COR) | United States | $57.058B | 19.85 |
| DiDi Global (DIDIY) | China | $27.204B | 28.90 |
| Labcorp Holdings (LH) | United States | $20.694B | 16.78 |
| Natera (NTRA) | United States | $19.578B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.107B | 0.00 |
| Solventum (SOLV) | United States | $12.779B | 13.53 |
| ICON (ICLR) | Ireland | $11.862B | 11.03 |
| Revvity (RVTY) | United States | $11.266B | 19.39 |
| Viatris (VTRS) | United States | $10.880B | 3.74 |
| Medpace Holdings (MEDP) | United States | $9.173B | 24.36 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.822B | 0.00 |
| HealthEquity (HQY) | United States | $8.658B | 37.92 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.959B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.696B | 15.08 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.017B | 29.54 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.899B | 37.70 |
| Alignment Healthcare (ALHC) | United States | $2.602B | 0.00 |
| Concentras Parent (CON) | United States | $2.533B | 14.64 |
| Organon (OGN) | United States | $2.506B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.295B | 88.37 |
| Progyny (PGNY) | United States | $1.972B | 43.42 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Premier (PINC) | United States | $1.735B | 13.17 |
| GoodRx Holdings (GDRX) | United States | $1.689B | 33.79 |
| Ardent Health (ARDT) | United States | $1.656B | 7.06 |
| Teladoc Health (TDOC) | United States | $1.410B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.103B | 8.39 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.898B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.779B | 7.29 |
| CareDx (CDNA) | United States | $0.658B | 10.27 |
| Nutex Health (NUTX) | United States | $0.615B | 9.32 |
| Embecta (EMBC) | United States | $0.576B | 3.88 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.569B | 0.00 |
| So-Young (SY) | China | $0.507B | 0.00 |
| LifeMD (LFMD) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.476B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.68 |
| Omada Health (OMDA) | $0.456B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.315B | 0.00 |
| Beauty Health (SKIN) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Pheton Holdings (PTHL) | China | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.113B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.052B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |